Review




Structured Review

ProSense Inc prosense-680 + cd11b + f4/80 + cells
(Α) Histology of polyps from APC Δ468 mouse. (a–b) CEA stained paraffin sections counterstained with Gill's II Hematoxylin; (c&d) methylene blue staining; arrows point to (a) granulocytes, (b) mast cells, (c) plasma cells, (d) lymphocytes. (B) Immuno-fluorescence of polyps from APC Δ468 mice. Cryosections were stained with (a) DAPI, (b) <t>CD11b-AlexaFluor</t> 488, and (c) Gr1-AlexaFluor 594. Arrows point to polyp, and arrowheads to the adjacent healthy villus; note accumulation of CD11b + cells and/or Gr1 + cells in the polyps. (C) FACS analysis of leukocytes prepared from micro-dissected polyps, and from adjacent tissue (n = 4), and of intestinal tissue from age-matched healthy control mice (n = 3). Mean values and SEM are shown for frequencies of CD11b + and of CD11b + Gr1 + cells in 6 month-old mice.
Prosense 680 + Cd11b + F4/80 + Cells, supplied by ProSense Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11b+cells/prosense+680+++cd11b+++f4+80+++cells/pmc02488397-98-6-3
Average 90 stars, based on 1 article reviews
prosense-680 + cd11b + f4/80 + cells - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Live Imaging of Cysteine-Cathepsin Activity Reveals Dynamics of Focal Inflammation, Angiogenesis, and Polyp Growth"

Article Title: Live Imaging of Cysteine-Cathepsin Activity Reveals Dynamics of Focal Inflammation, Angiogenesis, and Polyp Growth

Journal: PLoS ONE

doi: 10.1371/journal.pone.0002916

(Α) Histology of polyps from APC Δ468 mouse. (a–b) CEA stained paraffin sections counterstained with Gill's II Hematoxylin; (c&d) methylene blue staining; arrows point to (a) granulocytes, (b) mast cells, (c) plasma cells, (d) lymphocytes. (B) Immuno-fluorescence of polyps from APC Δ468 mice. Cryosections were stained with (a) DAPI, (b) CD11b-AlexaFluor 488, and (c) Gr1-AlexaFluor 594. Arrows point to polyp, and arrowheads to the adjacent healthy villus; note accumulation of CD11b + cells and/or Gr1 + cells in the polyps. (C) FACS analysis of leukocytes prepared from micro-dissected polyps, and from adjacent tissue (n = 4), and of intestinal tissue from age-matched healthy control mice (n = 3). Mean values and SEM are shown for frequencies of CD11b + and of CD11b + Gr1 + cells in 6 month-old mice.
Figure Legend Snippet: (Α) Histology of polyps from APC Δ468 mouse. (a–b) CEA stained paraffin sections counterstained with Gill's II Hematoxylin; (c&d) methylene blue staining; arrows point to (a) granulocytes, (b) mast cells, (c) plasma cells, (d) lymphocytes. (B) Immuno-fluorescence of polyps from APC Δ468 mice. Cryosections were stained with (a) DAPI, (b) CD11b-AlexaFluor 488, and (c) Gr1-AlexaFluor 594. Arrows point to polyp, and arrowheads to the adjacent healthy villus; note accumulation of CD11b + cells and/or Gr1 + cells in the polyps. (C) FACS analysis of leukocytes prepared from micro-dissected polyps, and from adjacent tissue (n = 4), and of intestinal tissue from age-matched healthy control mice (n = 3). Mean values and SEM are shown for frequencies of CD11b + and of CD11b + Gr1 + cells in 6 month-old mice.

Techniques Used: Staining, Clinical Proteomics, Fluorescence, Control

(A) FACS analyses of pro-inflammatory cells. (a) Exemplar FACS analyses of mononuclear cells prepared from the intestine of (a&c) a 5 month-old APC Δ468 mouse and (b&d) an age matched wt C57BL/6J mouse; note increases in the frequencies of (a) CD11b + Gr1 + and (c) CD11b + F4/80 + myeloid type cells in the polyposis intestine, compared to wt tissue (b&d respectively). (B) Summary of FACS analysis of MNCs from wt (black bars) or APC Δ468 (open bars) intestine, showing mean frequencies and absolute numbers of cells with SEM values; n = 6 for APC Δ468 , n = 3 for wt control mice, per age group.
Figure Legend Snippet: (A) FACS analyses of pro-inflammatory cells. (a) Exemplar FACS analyses of mononuclear cells prepared from the intestine of (a&c) a 5 month-old APC Δ468 mouse and (b&d) an age matched wt C57BL/6J mouse; note increases in the frequencies of (a) CD11b + Gr1 + and (c) CD11b + F4/80 + myeloid type cells in the polyposis intestine, compared to wt tissue (b&d respectively). (B) Summary of FACS analysis of MNCs from wt (black bars) or APC Δ468 (open bars) intestine, showing mean frequencies and absolute numbers of cells with SEM values; n = 6 for APC Δ468 , n = 3 for wt control mice, per age group.

Techniques Used: Control

Cryosections of ProSense-680 in vivo stained intestine from APC Δ468 mice were stained with antibodies to CD11b (AlexaFluor 488), Gr1 (AlexaFluor 594) and DAPI. The merged images of CD11b with DAPI (a, CD11b green, DAPI gray), Gr1 with DAPI (b, Gr1 red, DAPI gray), and ProSense-680 with DAPI (c, ProSense-680 blue, DAPI gray) were produced with the “RGB gray” plug-in of Image J. The “colocalization finder” plug-in produced images where the colocalized pixels appear white while the ProSense-680 was red (d&e), the CD11b was green (d, colocalization analysis of ProSense-680 and CD11b staining) and the Gr1 was green (e, colocalization analysis of ProSense-680 and Gr1 staining). ×400 magnification. Arrows mark a CD11b + Gr1 ProSense 680 + cell. Representative FACS dot-plots of MNCs prepared from polyposis intestine and ex vivo stained with ProSense-680 followed by CD11b and Gr1 staining. The live MNCs were gated for ProSence-680 + cells, which were analyzed for CD11b + Gr1 + (f, MDSCs) and CD11b + F4/80 + (g, macrophages) cells. Cumulative results of 6 FACS experiments showing % of CD11b + Gr1 + ProSense-680 + and CD11b + F4/80 + ProSense 680 + among total infiltrating MNCs. Note that among the ProSense-680 + cells (11±0.69% of total MNCs) over 75% were either CD11b + Gr1 + (3.4±0.6% of total MNCs) or CD11b + F4/80 (5.0±0.34% of total MNCs).
Figure Legend Snippet: Cryosections of ProSense-680 in vivo stained intestine from APC Δ468 mice were stained with antibodies to CD11b (AlexaFluor 488), Gr1 (AlexaFluor 594) and DAPI. The merged images of CD11b with DAPI (a, CD11b green, DAPI gray), Gr1 with DAPI (b, Gr1 red, DAPI gray), and ProSense-680 with DAPI (c, ProSense-680 blue, DAPI gray) were produced with the “RGB gray” plug-in of Image J. The “colocalization finder” plug-in produced images where the colocalized pixels appear white while the ProSense-680 was red (d&e), the CD11b was green (d, colocalization analysis of ProSense-680 and CD11b staining) and the Gr1 was green (e, colocalization analysis of ProSense-680 and Gr1 staining). ×400 magnification. Arrows mark a CD11b + Gr1 ProSense 680 + cell. Representative FACS dot-plots of MNCs prepared from polyposis intestine and ex vivo stained with ProSense-680 followed by CD11b and Gr1 staining. The live MNCs were gated for ProSence-680 + cells, which were analyzed for CD11b + Gr1 + (f, MDSCs) and CD11b + F4/80 + (g, macrophages) cells. Cumulative results of 6 FACS experiments showing % of CD11b + Gr1 + ProSense-680 + and CD11b + F4/80 + ProSense 680 + among total infiltrating MNCs. Note that among the ProSense-680 + cells (11±0.69% of total MNCs) over 75% were either CD11b + Gr1 + (3.4±0.6% of total MNCs) or CD11b + F4/80 (5.0±0.34% of total MNCs).

Techniques Used: In Vivo, Staining, Produced, Ex Vivo

(a) Non-linear regression analysis of polyp number and diameter, assuming Gaussian distribution; APC Δ468 Ctsb −/− (continued line, open squares), and APC Δ468 (dotted line, closed triangles). Note that Cathepsin B −/− mice had fewer and smaller polyps. (b) Frequencies of ProSense-680 active leukocytes amongst total MNCs prepared from the intestine of APC Δ468 (open bar, 6.7%±086%) or APC Δ468 Ctsb −/− (filled bar, 11%±0.69%, P = 0.0037; unpaired t test with Welsh correction). (c) Frequencies of ProSense-680 active CD11b + Gr1 + (mean 0.56%) or CD11b + F4/80 + (mean 4.46%) cells, from the intestines of APC Δ468 (open bar) and APC Δ468 Ctsb −/− mice (filled bars); P<0.001, n = 6, 2way ANOVA. Note that Cathepsin B deficiency predominantly impacted the abundance of CD11b + Gr1 + cells. (d) Attenuation of polyposis in anti-TNFα treated mice (solid line, open squares, n = 6), as compared to the APC Δ468 (dotted line & closed triangles). (e) Frequencies of CD11b + Gr1 + amongst total intestine live MNCs; APC Δ468 Ctsb −/− intestine (light gray bar, 0.56±0.15%, P<0.001), anti-TNFα treated (dark gray bar, 0.71±0.22%, P<0.001), untreated APC Δ468 (open bar, 4.2±0.093%), wt control intestine (black bar, 0.15±0.051%). (f) Frequencies of CD11b + F4/80 + in the APC Δ468 (5.03±0.78%), APC Δ468 Ctsb −/− intestine (5.36±0.92%), and anti-TNFα treated intestine (dark gray bar, 3.0±0.67%).
Figure Legend Snippet: (a) Non-linear regression analysis of polyp number and diameter, assuming Gaussian distribution; APC Δ468 Ctsb −/− (continued line, open squares), and APC Δ468 (dotted line, closed triangles). Note that Cathepsin B −/− mice had fewer and smaller polyps. (b) Frequencies of ProSense-680 active leukocytes amongst total MNCs prepared from the intestine of APC Δ468 (open bar, 6.7%±086%) or APC Δ468 Ctsb −/− (filled bar, 11%±0.69%, P = 0.0037; unpaired t test with Welsh correction). (c) Frequencies of ProSense-680 active CD11b + Gr1 + (mean 0.56%) or CD11b + F4/80 + (mean 4.46%) cells, from the intestines of APC Δ468 (open bar) and APC Δ468 Ctsb −/− mice (filled bars); P<0.001, n = 6, 2way ANOVA. Note that Cathepsin B deficiency predominantly impacted the abundance of CD11b + Gr1 + cells. (d) Attenuation of polyposis in anti-TNFα treated mice (solid line, open squares, n = 6), as compared to the APC Δ468 (dotted line & closed triangles). (e) Frequencies of CD11b + Gr1 + amongst total intestine live MNCs; APC Δ468 Ctsb −/− intestine (light gray bar, 0.56±0.15%, P<0.001), anti-TNFα treated (dark gray bar, 0.71±0.22%, P<0.001), untreated APC Δ468 (open bar, 4.2±0.093%), wt control intestine (black bar, 0.15±0.051%). (f) Frequencies of CD11b + F4/80 + in the APC Δ468 (5.03±0.78%), APC Δ468 Ctsb −/− intestine (5.36±0.92%), and anti-TNFα treated intestine (dark gray bar, 3.0±0.67%).

Techniques Used: Control

Related Articles

other:

Article Title:
Article Snippet: The frequencies of ProSense-680 + , CD11b + F4/80 + cells remain unchanged (mean 5.36% to 5.03% respectively).



Similar Products

96
Miltenyi Biotec cells
Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11b+cells/CD11b+MicroBeads%2C+human+and+mouse/pm42468469-103-3-9
Average 96 stars, based on 1 article reviews
cells - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Miltenyi Biotec single cell suspensions
Single Cell Suspensions, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11b+cells/CD11b+MicroBeads+UltraPure%2C+mouse/bio_rxiv__64898__2026__06__04__730038-363-13-32
Average 95 stars, based on 1 article reviews
single cell suspensions - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Miltenyi Biotec cell suspension
Cell Suspension, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11b+cells/CD11b+(Microglia)+MicroBeads%2C+human+and+mouse+-+small+size/pmc13218475-177-9-25
Average 96 stars, based on 1 article reviews
cell suspension - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Miltenyi Biotec cd11b magnetic activated cell sorting macs system
Cd11b Magnetic Activated Cell Sorting Macs System, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11b+cells/CD11b+MicroBeads%2C+human+and+mouse+-+lyophilized/pm42142538-61-20-26
Average 96 stars, based on 1 article reviews
cd11b magnetic activated cell sorting macs system - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

98
Miltenyi Biotec cd11b cells
Targeting USP14 inhibits tumor growth and induces local anti-tumor immunity in vivo (A) Representative images of MC38 tumors harvested on day 21 post-inoculation from mice treated with IU1 (20 mg/kg, i.p., on days 6, 9, 12, and 15) or vehicle control. (B) Statistics of MC38 tumor growth rate following IU1 or vehicle treatment in vivo . The intraperitoneal injection dose of IU1 was 20 mg/kg, administered on days 6, 9, 12, and 15. Data are presented as the mean ± SEM ( n = 6 per group). (C) Spider diagram of the tumor volume growth in each mouse from the IU1 group and the PBS group. (D) Gating strategy for the detection of the TAMs by flow cytometry. We first obtained live cells, and then identified cells that were positive for CD45, <t>CD11b,</t> F4-80, and CD206 as M2 macrophages. (E–P) Proportions of neutrophil (E), M2 macrophage (F), M1 macrophage (G), MDSC (H), activated DCs (I), CD4 T cell (J), Treg cells (K), CD8 T cell (L), IFN-γ + CD8 T cell (M), precursor exhausted T cells (TCF-1 + ) (N), effective CD8 T cells (PD-1 + ) (O) and activated CD8 T cell (CD69 + ) (P) in the TME of the IU1 group and the control group by using flow cytometry. (Q–U) Cytokines IFN-γ (Q), TNF-α (R), IL-2 (S), IL-10 (T), and IL-12 (U) in the TME of each group were detected by Mul-Analyte Flow Assay Kit. (V) Schematic illustration of the proposed mechanism of action of IU1 in reprogramming the tumor microenvironment. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
Cd11b Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11b+cells/CD11b%2Fc+Antibody%2C+anti-rat%2C+REAfinity/pmc13122227-330-5-19
Average 98 stars, based on 1 article reviews
cd11b cells - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

95
Miltenyi Biotec mouse bone marrow cells
Targeting USP14 inhibits tumor growth and induces local anti-tumor immunity in vivo (A) Representative images of MC38 tumors harvested on day 21 post-inoculation from mice treated with IU1 (20 mg/kg, i.p., on days 6, 9, 12, and 15) or vehicle control. (B) Statistics of MC38 tumor growth rate following IU1 or vehicle treatment in vivo . The intraperitoneal injection dose of IU1 was 20 mg/kg, administered on days 6, 9, 12, and 15. Data are presented as the mean ± SEM ( n = 6 per group). (C) Spider diagram of the tumor volume growth in each mouse from the IU1 group and the PBS group. (D) Gating strategy for the detection of the TAMs by flow cytometry. We first obtained live cells, and then identified cells that were positive for CD45, <t>CD11b,</t> F4-80, and CD206 as M2 macrophages. (E–P) Proportions of neutrophil (E), M2 macrophage (F), M1 macrophage (G), MDSC (H), activated DCs (I), CD4 T cell (J), Treg cells (K), CD8 T cell (L), IFN-γ + CD8 T cell (M), precursor exhausted T cells (TCF-1 + ) (N), effective CD8 T cells (PD-1 + ) (O) and activated CD8 T cell (CD69 + ) (P) in the TME of the IU1 group and the control group by using flow cytometry. (Q–U) Cytokines IFN-γ (Q), TNF-α (R), IL-2 (S), IL-10 (T), and IL-12 (U) in the TME of each group were detected by Mul-Analyte Flow Assay Kit. (V) Schematic illustration of the proposed mechanism of action of IU1 in reprogramming the tumor microenvironment. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.
Mouse Bone Marrow Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd11b+cells/CD11b+MicroBeads+UltraPure%2C+mouse/pmc12995707-369-9-20
Average 95 stars, based on 1 article reviews
mouse bone marrow cells - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


Targeting USP14 inhibits tumor growth and induces local anti-tumor immunity in vivo (A) Representative images of MC38 tumors harvested on day 21 post-inoculation from mice treated with IU1 (20 mg/kg, i.p., on days 6, 9, 12, and 15) or vehicle control. (B) Statistics of MC38 tumor growth rate following IU1 or vehicle treatment in vivo . The intraperitoneal injection dose of IU1 was 20 mg/kg, administered on days 6, 9, 12, and 15. Data are presented as the mean ± SEM ( n = 6 per group). (C) Spider diagram of the tumor volume growth in each mouse from the IU1 group and the PBS group. (D) Gating strategy for the detection of the TAMs by flow cytometry. We first obtained live cells, and then identified cells that were positive for CD45, CD11b, F4-80, and CD206 as M2 macrophages. (E–P) Proportions of neutrophil (E), M2 macrophage (F), M1 macrophage (G), MDSC (H), activated DCs (I), CD4 T cell (J), Treg cells (K), CD8 T cell (L), IFN-γ + CD8 T cell (M), precursor exhausted T cells (TCF-1 + ) (N), effective CD8 T cells (PD-1 + ) (O) and activated CD8 T cell (CD69 + ) (P) in the TME of the IU1 group and the control group by using flow cytometry. (Q–U) Cytokines IFN-γ (Q), TNF-α (R), IL-2 (S), IL-10 (T), and IL-12 (U) in the TME of each group were detected by Mul-Analyte Flow Assay Kit. (V) Schematic illustration of the proposed mechanism of action of IU1 in reprogramming the tumor microenvironment. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.

Journal: iScience

Article Title: Targeting USP14 enhances immunotherapy response by reprogramming tumor-associated macrophages in colon cancer

doi: 10.1016/j.isci.2026.115362

Figure Lengend Snippet: Targeting USP14 inhibits tumor growth and induces local anti-tumor immunity in vivo (A) Representative images of MC38 tumors harvested on day 21 post-inoculation from mice treated with IU1 (20 mg/kg, i.p., on days 6, 9, 12, and 15) or vehicle control. (B) Statistics of MC38 tumor growth rate following IU1 or vehicle treatment in vivo . The intraperitoneal injection dose of IU1 was 20 mg/kg, administered on days 6, 9, 12, and 15. Data are presented as the mean ± SEM ( n = 6 per group). (C) Spider diagram of the tumor volume growth in each mouse from the IU1 group and the PBS group. (D) Gating strategy for the detection of the TAMs by flow cytometry. We first obtained live cells, and then identified cells that were positive for CD45, CD11b, F4-80, and CD206 as M2 macrophages. (E–P) Proportions of neutrophil (E), M2 macrophage (F), M1 macrophage (G), MDSC (H), activated DCs (I), CD4 T cell (J), Treg cells (K), CD8 T cell (L), IFN-γ + CD8 T cell (M), precursor exhausted T cells (TCF-1 + ) (N), effective CD8 T cells (PD-1 + ) (O) and activated CD8 T cell (CD69 + ) (P) in the TME of the IU1 group and the control group by using flow cytometry. (Q–U) Cytokines IFN-γ (Q), TNF-α (R), IL-2 (S), IL-10 (T), and IL-12 (U) in the TME of each group were detected by Mul-Analyte Flow Assay Kit. (V) Schematic illustration of the proposed mechanism of action of IU1 in reprogramming the tumor microenvironment. Data are presented as the mean ± SEM. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001, and ns: not significant.

Article Snippet: For RNA and protein extraction, CD11b + cells were first enriched using magnetic-activated cell sorting (MACS) with anti-CD11b microbeads (Miltenyi Biotec) according to the manufacturer’s protocol.

Techniques: In Vivo, Control, Injection, Flow Cytometry